|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/70 |
| (11) | Number of the document | 1748766 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05740148.1 |
| Date of filing the European patent application | 2005-04-21 | |
| (97) | Date of publication of the European application | 2007-02-07 |
| (45) | Date of publication and mention of the grant of the patent | 2014-06-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/014021 |
| Date | 2005-04-21 |
| (87) | Number | WO 2005/110380 |
| Date | 2005-11-24 |
| (30) | Number | Date | Country code |
| 836880 | 2004-04-30 | US |
| (72) |
HUANG, Glenn, T., US
NIVAGGIOLI, Thierry, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | SUSTAINED RELEASE INTRAOCULAR IMPLANTS COMPRISING A BETA ADRENERGIC RECEPTOR ANTAGONIST AND METHODS FOR TREATING OCULAR NEUROPATHIES |
| SUSTAINED RELEASE INTRAOCULAR IMPLANTS COMPRISING A BETA ADRENERGIC RECEPTOR ANTAGONIST AND METHODS FOR TREATING OCULAR NEUROPATHIES |